ResMed Delivers Strong Start to Fiscal 2026 with Solid Margin Expansion

ResMed Inc. (ASX: RMD) released its first-quarter results for fiscal year 2026, highlighting strong financial growth and meaningful advancements in its strategic initiatives. Revenue rose 9% year-over-year to US$1.34 billion, driven by higher demand for sleep devices, masks, and accessories. The company’s gross margin improved 290 basis points to 61.5%, reflecting efficiency gains and lower component costs. Net income reached US$349 million, with non-GAAP earnings per share up 16% to US$2.55. Operating cash flow stood at US$457 million, highlighting strong liquidity. ResMed continued capital returns, distributing US$88 million in dividends and repurchasing 523,000 shares worth US$150 million. Key highlights included new AI-powered digital health initiatives, product design awards, and leadership updates. CEO Mick Farrell emphasized ResMed’s commitment to expanding home-based healthcare through innovation and operational excellence, positioning the company for sustainable, profitable growth in fiscal 2026

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com